Wai Yuen Tong Medicine Holdings (HKSE:00897) Operating Cash Flow per Share : HK$0.19 (TTM As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Operating Cash Flow per Share?

Wai Yuen Tong Medicine Holdings's operating cash flow per share for the six months ended in Sep. 2023 was HK$0.06. Wai Yuen Tong Medicine Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.19.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Wai Yuen Tong Medicine Holdings was 20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Wai Yuen Tong Medicine Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.10% per year. The lowest was -68.10% per year. And the median was -4.30% per year.

HKSE:00897's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Wai Yuen Tong Medicine Holdings Operating Cash Flow per Share Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Operating Cash Flow per Share Chart

Wai Yuen Tong Medicine Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.02

-0.03

0.34

0.14

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.02	0.16	-	0.14	0.06

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Price-to-Operating-Cash-Flow falls into.

Wai Yuen Tong Medicine Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )	=	Cash Flow from Operations (A: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2023 )
	=	165.815	/	1216.213
	=	0.14

Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	67.355	/	1191.589
	=	0.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.19

Wai Yuen Tong Medicine Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG

Website

https://www.wyth.net

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.

Executives

Wang On Group Limited	2501 Other
Tang Ching Ho	2501 Other
Yau Yuk Yin	2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines